Vast Therapeutics
  • Home
  • About
    • Company Overview
    • Board of Directors
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Overview
    • Scientific Papers
  • Cystic Fibrosis
  • Investors
  • News
  • Contact
Picture

Vast Therapeutics is a preclinical stage biotechnology company developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.

​About Us

​Vast Therapeutics is a development-stage pharmaceutical company that develops therapies to treat resistant bacteria and enable patients suffering from severe respiratory diseases to breathe better and live life more fully.
Learn More

​Technology

​Vast Therapeutics’ solutions will provide cystic fibrosis patients with a convenient and effective inhalable treatment for drug-resistant respiratory infections.

​
Learn More

​Investors

​We are committed to bring breakthrough antimicrobial therapies to market that address the growing needs of patients with severe lung diseases like cystic fibrosis.

​
Learn More

RECENT NEWS

Vast Therapeutics Announces BIOC11 testing results for Nontuberculous Mycobacteria (NTM) in Animal Model

Oct 22, 2019

​DURHAM, N.C., Oct. 22, 2019 -- Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, announces that BIOC11 eradicated 99% of the Nontuberculous Mycobacteria (NTM) in an in vivo animal model of infection; this data will be presented at the National Cystic Fibrosis Conference to be held in Nashville, Tennessee from October 31 to November 2, 2019.
Learn More
​Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11

Oct 8, 2019

DURHAM, NC – October 8, 2019 – Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, today announced that another of its drug candidates, BIOC11, has been designated as a “Qualified Infectious
Disease Product” (QIDP) by the U.S. Food and Drug Administration. 
​

​
Learn More
​KNOW Bio Announces Closing of $30 Million in Equity Financing

May 15, 2019

DURHAM, N.C., May 15, 2019 /PRNewswire/ -- KNOW Bio, LLC, (the Company or KNOW Bio), an RTP based conglomerate of biotechnology and MedTech companies, announced today that the Company has completed its next round of financing with a single investor, Reedy Creek Investments, LLC (Reedy Creek).


​
Learn More
Picture

Address

​4222 Emperor Blvd. Suite 470
​Durham, NC 27703

Contact Us

info@vasttherapeutics.com

Sector

Biopharmaceutical

Industry

​Biotechnology
​Forward-Looking Statement | Privacy | Terms of Use | Site Map
​Copyright © 2019 Vast Therapeutics - All Rights Reserved
  • Home
  • About
    • Company Overview
    • Board of Directors
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Overview
    • Scientific Papers
  • Cystic Fibrosis
  • Investors
  • News
  • Contact